Press releases
AM-Pharma Expands its Senior Team in Preparation for a Pivotal Phase III Trial of recAP in Acute Kidney Injury
Juliane Bernholz has joined as Chief Operating Officer
…
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
Financing co-led by new investors LSP and Andera Partners, with…
AM-Pharma haalt €116 miljoen ($133 miljoen) financiering op voor fase III registratie-studie met kandidaat-medicijn tegen acuut nierfalen (AKI)
Grootste biotech VC financieringsronde ooit in Nederland, geleid…
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury
View publication
JAMA publishes Phase II recAP data for sepsis-associated Acute Kidney Injury
JAMA paper to be presented at ESICM conference in Paris
New…